☆ 4.6 Article

Structure Activity Relationship Studies around DB18, a Potent and Selective Inhibitor of CLK Kinases

MOLECULES (2022)

Related references

Note: Only part of the references are listed.

Article Chemistry, Medicinal

Small Molecule Kinase Inhibitor Drugs (1995-2021): Medical Indication, Pharmacology, and Synthesis

Cecilia C. Ayala-Aguilera et al.

Summary: Kinase inhibitors play a central role in the treatment of progressive disorders, with FDA approving 73 small molecule kinase inhibitor drugs by September 2021. This review summarizes the therapeutic and pharmacological properties of approved kinase inhibitors, as well as their synthesis routes, with an update on drugs approved in 2021.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Review Pharmacology & Pharmacy

Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update

Robert Roskoski

Summary: This article discusses the importance of protein kinase inhibitors in drug therapy, covering the therapeutic targets, types, and indications of 62 FDA-approved drugs. It summarizes the physicochemical properties of these drugs, emphasizing their wide applications in the treatment of diseases such as tumors and inflammatory conditions.

PHARMACOLOGICAL RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinase

Dabbugoddu Brahmaiah et al.

Summary: A novel series of anilino-2-quinazoline derivatives were synthesized and tested for their inhibitory effects on CDC2-like kinases. One compound, DB18, showed potent inhibition on CLK1, CLK2, and CLK4, while remaining inactive on DYRK1A, demonstrating selectivity in its inhibitory activity. Molecular simulation studies were conducted to elucidate the underlying mechanisms of the compound's strong affinity for CLKs and its selectivity against DYRK1A.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview

Mattias F. Lindberg et al.

Summary: DYRK and CLK kinases are involved in various cellular functions and their abnormal expression/activity are linked to multiple neurological diseases, cancers, and other conditions. Research on the regulation of these kinases and the development of inhibitors is crucial for the treatment of related diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Chemistry, Medicinal

Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B

David Lee Walmsley et al.

Summary: The serine/threonine kinase DYRK1A is associated with cancer progression and severity of symptoms in Down's syndrome. A highly selective and well-tolerated DYRK1A inhibitor has been identified, showing in vivo activity in a tumor model, and providing a useful tool for further research on the effects of DYRK1A inhibition in disease models.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Oncology

The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models

Betty Y. Tam et al.

CANCER LETTERS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential

Paula Martin Moyano et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Chemistry, Medicinal

New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis

Helmi Tazarki et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Furo[3,2-b]pyridine: A Privileged Scaffold for Highly Selective Kinase Inhibitors and Effective Modulators of the Hedgehog Pathway

Vaclav Nemec et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

Add to Collection

Article Chemistry, Medicinal

Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers

Qi-Zheng Sun et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Add to Collection

Article Chemistry, Organic

Reaction of azides and enolisable aldehydes under the catalysis of organic bases and Cinchona based quaternary ammonium salts

Dario Destro et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2017)

Add to Collection

Review Pharmacology & Pharmacy

Ten things you should know about protein kinases: IUPHAR Review 14

Doriano Fabbro et al.

BRITISH JOURNAL OF PHARMACOLOGY (2015)

Add to Collection

Review Cell Biology

Connecting the speckles: Splicing kinases and their role in tumorigenesis and treatment response

Dale P. Corkery et al.

NUCLEUS (2015)

Add to Collection

Review Cell Biology

Connecting the speckles: Splicing kinases and their role in tumorigenesis and treatment response

Dale P. Corkery et al.

NUCLEUS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Evaluation of Cancer Dependence and Druggability of PRP4 Kinase Using Cellular, Biochemical, and Structural Approaches

Qiang Gao et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Potent small molecule Hedgehog agonists induce VEGF expression in vitro

Katrin Seifert et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2012)

Add to Collection

Article Biochemical Research Methods

ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for Kinases

Hicham Zegzouti et al.

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2009)

Add to Collection

Review Biochemistry & Molecular Biology

The Spliceosome: Design Principles of a Dynamic RNP Machine

Markus C. Wahl et al.

CELL (2009)

Add to Collection

Article Chemistry, Multidisciplinary

Copper-free azide-alkyne cycloadditions: New insights and perspectives

Jean-Francois Lutz

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)

Add to Collection

Article Chemistry, Organic

Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides

CW Tornoe et al.

JOURNAL OF ORGANIC CHEMISTRY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.